4//SEC Filing
Lyski James 4
Accession 0001170010-23-000042
CIK 0001170010other
Filed
May 2, 8:00 PM ET
Accepted
May 3, 4:32 PM ET
Size
10.9 KB
Accession
0001170010-23-000042
Insider Transaction Report
Form 4
CARMAX INCKMX
Lyski James
SVP & Chief Marketing Officer
Transactions
- Exercise/Conversion
Common Stock
2023-05-01+3,527→ 22,848 total - Tax Payment
Common Stock
2023-05-01$70.48/sh−1,062$74,850→ 21,786 total - Exercise/Conversion
Restricted Stock Units
2023-05-01−3,884→ 0 total→ Common Stock (3,527 underlying) - Award
Stock Options (Right to Buy)
2023-05-01+44,877→ 44,877 totalExercise: $70.48Exp: 2030-05-01→ Common Stock (44,877 underlying)
Footnotes (4)
- [F1]Following vesting of the restricted stock units, which are referred to by the Company as market stock units (MSUs), the Reporting Person received 0.91 times the number of MSUs in shares of Company common stock.
- [F2]The restricted stock units vested on May 1, 2023 and were settled in Company common stock.
- [F3]The stock options were granted in tandem with stock appreciation rights (SARS). Accordingly, the exercise of one results in the surrender to the Company of the other. The SARS become exercisable only following a change in control of the Company as set forth in the Company's 2002 Stock Incentive Plan, as amended and restated. Once exercisable, the SARS would entitle the Reporting Person to receive the cash value of the options in lieu of exercising the options.
- [F4]The stock options become exercisable with respect to one-fourth of the underlying shares of Common Stock on each of May 1, 2024, May 1, 2025, May 1, 2026 and May 1, 2027.
Documents
Issuer
CARMAX INC
CIK 0001170010
Entity typeother
Related Parties
1- filerCIK 0001376853
Filing Metadata
- Form type
- 4
- Filed
- May 2, 8:00 PM ET
- Accepted
- May 3, 4:32 PM ET
- Size
- 10.9 KB